Charles River Laboratories International Inc stock is traded at $333.17, with a volume of 28,143. It is down -1.42% in the last 24 hours and up +11.00% over the past month. Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Previous Close:
$337.97
Open:
$334.13
24h Volume:
28,143
Relative Volume:
0.02
Market Cap:
$15.96B
Revenue:
$4.03B
Net Income/Loss:
-$182.84M
P/E Ratio:
-
EPS:
-$3.76
Net Cash Flow:
$391.29M
1W Performance:
-5.71%
1M Performance:
+11.00%
6M Performance:
+120.86%
1Y Performance:
+98.54%
1-Day Range:
$328.68$335.13
1-Week Range:
$326.29$356.00
52-Week Range:
$146.20$379.63
Charles River Laboratories International Inc Stock (CRL) Company Profile
Name
Charles River Laboratories International IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
781-222-6000Address
251 BALLARDVALE ST, WILMINGTON, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS